Keyword: Generic drugs
From Brands to Generics - No Monopoly, No Competition (7/31/2002)
By providing incentives for brand-name drug companies to fund expensive R&D, temporary patents for expensive blockbuster drugs inadvertently lead to cheaper generic rivals when the patents expire.
Keywords: bioequivalent, brand-name drugs, competition, Generic drugs, Hatch-Waxman Act, monopoly, patent, prescription drugs
Power Play (7/31/2002)
Market competition requires a balance of power between buyers and sellers.
Keywords: balance of power, brand-name drugs, Generic drugs, Hatch-Waxman Act, HMO, managed care, patent, prescription drugs, Prozac